Delivery Order SPE2DR25D2206-SPE2DR26F9LS2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $149,037.80 and a firm fixed price structure. This contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $1 billion vehicle valued through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $37,259.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of JEMPERLI 500 mg/10 mL vials. This non-set-aside competitive award was issued on August 1, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. JEMPERLI is a specialized pharmaceutical product, and this order represents one of many...
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15.7K to supply Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026. The award represents a non-competitive, non-set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December 2026. Performance...
- The Defense Logistics Agency awarded a $29.8K delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with a completion date of November 10, 2025, with performance conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of JEMPERLI 500 mg/10 ml vials valued at $74,518.90 with a firm fixed price structure. The contract, which is not set-aside, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $78,531.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Jemperli 500 mg/10 mL vials. The contract, with an ultimate completion date of January 15, 2026, represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $29,807.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jemperli 500 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Jemperli (venetoclax) 500 mg/10 mL vials. This $22,355.67 firm fixed-price delivery order carries an ultimate completion date of October 15, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $113,363.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9LS2Delivery Order
The Defense Logistics Agency awarded a $24,468.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Jemperli 500 mg/10 ml vials. This non-competitive delivery order is scheduled for completion by February 9, 2026, with fulfillment occurring at the awardee's facility in Conshohocken, Pennsylvania. Jemperli is a specialized oncology medication used in the treatment of certain hematologic malignancies, representing the type of critical pharmaceutical commodity that the Defense Logistics Agency procures to support military healthcare systems and veteran medical facilities. This delivery order was issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This primary contract vehicle enables Cencora to supply a comprehensive range of pharmaceutical products, specialty medications, generic drugs, vaccines, and medical supplies to support global military healthcare operations. As the prime contractor on this IDC, Cencora leverages its extensive pharmaceutical distribution network to fulfill critical medical supply needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 1/15/26 |